Back
Edwards Lifesciences 10K Form
Sell
29
EW
Edwards Lifesciences
Last Price:
66.55
Seasonality Move:
11.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-29 | 10Q | EW/Edwards Lifesciences Quarterly |
| 2024-02-12 | 10K | EW/Edwards Lifesciences Annual |
| 2023-10-27 | 10Q | EW/Edwards Lifesciences Quarterly |
| 2023-07-28 | 10Q | EW/Edwards Lifesciences Quarterly |
| 2023-04-28 | 10Q | EW/Edwards Lifesciences Quarterly |
| 2023-02-13 | 10K | EW/Edwards Lifesciences Annual |
Receive EW News And Ratings
See the #1 stock for the next 7 days that we like better than EW
EW Financial Statistics
Sales & Book Value
| Annual Sales: | $6B |
|---|---|
| Cash Flow: | $294.5M |
| Price / Cash Flow: | 81.02 |
| Annual Sales: | $16.18 |
| Price / Book: | 4.07 |
Profitability
| EPS (TTM): | 6.93000 |
|---|---|
| Net Income (TTM): | $4.16B |
| Gross Margin: | $4.63B |
| Return on Equity: | 55.09% |
| Return on Assets: | 40.35% |
Edwards Lifesciences Earnings Forecast
Key Edwards Lifesciences Financial Ratios
- The Gross Profit Margin over the past 25 years for EW is 77.02%.
- The Selling, General & Administrative Expenses for EW have been equal to 30.39% of Gross Profit Margin.
- The Research & Development expenses have been 17.85% of Revenue.
- The Interest Expense is 1.25% of Operating Income.
- The Net Earning history of EW is 23.35% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 17 years.
Edwards Lifesciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | EW |
| CUSIP: | 28176E |
| Website: | edwards.com |
Debt
| Debt-to-Equity Ratio: | 0.06 |
|---|---|
| Current Ratio: | 3.46 |
| Quick Ratio: | 2.7 |
Price-to-Earnings
| Trailing P/E Ratio: | 28.61 |
|---|---|
| Forward P/E Ratio: | 26.68 |
EW Technical Analysis vs Fundamental Analysis
Sell
29
Edwards Lifesciences (EW)
is a Sell
Is Edwards Lifesciences a Buy or a Sell?
-
Edwards Lifesciences stock is rated a Sell
The current Edwards Lifesciences [EW] share price is $65.81. The Score for EW is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.